Section: Avian Bacteria

Avian Pasteurellosis (Fowl Cholera) in Poultry: Etiology, Epidemiology, Clinical Signs, and Control

Introduction

Avian pasteurellosis, commonly termed fowl cholera, is a contagious bacterial disease of domestic and wild birds caused by the Gram-negative coccobacillus Pasteurella multocida. The disease manifests in peracute, acute, and chronic forms and is responsible for significant economic losses in the poultry industry worldwide. Mortality rates in acute outbreaks can approach 50% or higher in susceptible flocks. This article provides a detailed review of the etiology, epidemiology, clinical signs, pathological findings, diagnostic methods, treatment options, and control measures for fowl cholera in poultry.

Etiology

The Causative Agent: Pasteurella multocida

Pasteurella multocida is a nonmotile, facultatively anaerobic, Gram-negative coccobacillus that exhibits bipolar staining with Wright or Giemsa stains. The bacterium is classified into five capsular serogroups (A, B, D, E, F) based on capsular polysaccharide antigens and 16 somatic lipopolysaccharide (LPS) serotypes (1 through 16) determined by gel diffusion precipitin tests. In poultry, the most commonly isolated capsular serogroups are A and F, with somatic serotypes 1, 3, and 4 being frequently associated with fowl cholera outbreaks. The bacterium produces a number of virulence factors, including a polysaccharide capsule that inhibits phagocytosis, lipopolysaccharide endotoxin that triggers septic shock, and outer membrane proteins that facilitate adhesion to host epithelial cells. Fimbriae and a sialidase enzyme also contribute to colonization of the respiratory mucosa.

Virulence Mechanisms

The pathogenesis of P. multocida infection begins with inhalation or ingestion of the organism. The bacterium adheres to the mucosal epithelium of the upper respiratory tract and oropharynx. Following colonization, it invades the submucosa and enters the bloodstream, leading to a fulminant septicemia. The capsular polysaccharide is a critical antiphagocytic factor; acapsular mutants are avirulent. The LPS endotoxin activates the complement cascade and induces a systemic inflammatory response characterized by increased vascular permeability, disseminated intravascular coagulation, and multiorgan failure. The bacterium also produces a dermonecrotic toxin (DNT) in some strains, though its role in avian disease is less clear than in porcine atrophic rhinitis.

Epidemiology

Host Range and Susceptibility

Fowl cholera affects a wide range of avian species. Chickens, turkeys, ducks, geese, and game birds such as pheasants and quail are highly susceptible. Waterfowl, particularly wild ducks and geese, serve as important reservoir hosts and can introduce the pathogen into domestic poultry flocks. Turkeys are generally more susceptible than chickens and often experience higher mortality rates. Young birds are less frequently affected than adults, although all ages can succumb under conditions of high challenge.

Transmission and Risk Factors

Transmission occurs horizontally through direct contact between infected and susceptible birds, via contaminated feed, water, and equipment, and through inhalation of aerosolized bacteria from respiratory secretions. Chronically infected carrier birds are the primary reservoir within a flock; they harbor the organism in the pharyngeal tonsils and sinuses without showing clinical signs. Stress factors that predispose flocks to outbreaks include overcrowding, poor ventilation, nutritional deficiencies, concurrent infections (e.g., mycoplasmosis, infectious coryza), and sudden environmental changes. The bacterium can survive for weeks in organic matter, soil, and water, facilitating indirect transmission between flocks.

Global Distribution

Fowl cholera has a worldwide distribution and is endemic in many regions with intensive poultry production. Outbreaks are more common in temperate climates during periods of cold, wet weather, which may stress birds and prolong bacterial survival in the environment. The disease is notifiable to the World Organisation for Animal Health (WOAH) in many countries due to its economic impact.

Clinical Signs

The clinical presentation of fowl cholera varies with the virulence of the P. multocida strain, the immune status of the host, and the route of exposure.

Peracute Form

In peracute cases, birds are found dead without premonitory signs. Mortality can spike rapidly, with losses occurring within 12 to 24 hours of initial infection. This form is most common in highly susceptible flocks, such as naive turkeys.

Acute Form

The acute form is the most frequently observed presentation. Clinical signs develop over 24 to 48 hours and include fever (elevated body temperature), depression, anorexia, ruffled feathers, cyanosis of the comb and wattles, and mucoid to bloody diarrhea. Respiratory signs such as dyspnea, rales, and nasal discharge are common. Affected birds may exhibit lameness due to septic arthritis. Mortality rates in acute outbreaks range from 20% to 50% in chickens and can exceed 50% in turkeys.

Chronic Form

Chronic fowl cholera results from infection with less virulent strains or from survival of acute disease. Localized infections develop in the wattles, sinuses, joints, and footpads. Characteristic lesions include swollen, caseous wattles (wattle edema), purulent sinusitis, and fibrinous arthritis. Chronic respiratory disease with persistent rales and nasal discharge is also observed. Birds may become emaciated and unthrifty. Carrier birds with chronic sinusitis or wattle infections serve as a source of infection for the rest of the flock.

Pathology

Gross Lesions

At necropsy, the most consistent finding in acute fowl cholera is generalized congestion and petechial hemorrhages on serosal surfaces, particularly the epicardium, pericardium, and abdominal fat. The liver is often enlarged, friable, and studded with multiple small, pale necrotic foci (miliary necrosis). The spleen may be swollen and mottled. The lungs are congested and edematous, and the trachea may contain frothy exudate. In chronic cases, caseous exudate is found in the wattles, sinuses, and joint cavities. Fibrinous pericarditis and perihepatitis are common in chronic infections.

Histopathology

Microscopic examination reveals acute necrotizing hepatitis with multifocal coagulative necrosis and infiltration of heterophils. In the spleen, there is lymphoid depletion and fibrinoid necrosis of arterioles. The lungs show congestion, edema, and heterophilic exudate in the air capillaries. In chronic cases, granulomatous inflammation with central caseous necrosis and a surrounding layer of epithelioid macrophages and giant cells is observed in affected wattles and joints.

Diagnosis

Clinical and Epidemiological Assessment

A presumptive diagnosis of fowl cholera is based on the history of acute mortality, characteristic clinical signs (cyanosis, diarrhea, respiratory distress), and gross pathological findings (petechial hemorrhages, hepatic necrosis). A rapid increase in mortality in adult birds, especially turkeys, is highly suggestive.

Laboratory Confirmation

Definitive diagnosis requires isolation and identification of P. multocida from affected tissues. Swabs of liver, spleen, lung, bone marrow, or heart blood are collected aseptically at necropsy. The samples are cultured on blood agar or MacConkey agar and incubated at 37 degrees Celsius under 5% carbon dioxide. P. multocida appears as small, gray, mucoid colonies that are nonhemolytic on blood agar. The organism is oxidase-positive, catalase-positive, and indole-positive. It does not grow on MacConkey agar. Bipolar staining of the organism in tissue impression smears stained with Wright or Giemsa stain provides a rapid preliminary identification.

Molecular Diagnostics

Polymerase chain reaction (PCR) assays targeting the P. multocida-specific KMT1 gene are used for rapid and specific detection of the bacterium directly from clinical samples. Capsular typing PCRs targeting the hyaD-hyaC (serogroup A), bcbD (serogroup B), dcbF (serogroup D), ecbJ (serogroup E), and fcbD (serogroup F) genes allow for molecular serogrouping. Somatic serotyping is performed using a multiplex PCR or by traditional gel diffusion precipitin tests with specific antisera. High-throughput sequencing technologies can be employed for whole-genome sequencing to investigate outbreak strain relatedness and antimicrobial resistance gene profiles.

Differential Diagnosis

Fowl cholera must be differentiated from other causes of acute septicemia and high mortality in poultry. Key differentials include highly pathogenic avian influenza (HPAI), Newcastle disease (velogenic viscerotropic form), fowl typhoid (Salmonella Gallinarum), pullorum disease (Salmonella Pullorum), and colibacillosis (Escherichia coli). Chronic forms must be differentiated from infectious coryza (Avibacterium paragallinarum), mycoplasmosis (Mycoplasma gallisepticum), and aspergillosis. Laboratory confirmation is essential for accurate diagnosis.

Treatment

Antimicrobial Therapy

Treatment of fowl cholera is based on the administration of antibiotics effective against P. multocida. Commonly used antimicrobials include tetracyclines (e.g., oxytetracycline, chlortetracycline), sulfonamides (e.g., sulfadimethoxine, sulfaquinoxaline), penicillins (e.g., amoxicillin, ampicillin), fluoroquinolones (e.g., enrofloxacin), and macrolides (e.g., tylosin, tilmicosin). Antibiotics are typically administered in the drinking water or feed for 5 to 7 days. Early treatment is critical to reduce mortality.

Antimicrobial Resistance

Antimicrobial resistance (AMR) in P. multocida is an emerging concern. Resistance to tetracyclines, sulfonamides, and penicillins has been reported in various regions. The acquisition of resistance genes, such as tet(H) for tetracycline resistance and blaROB-1 for beta-lactam resistance, is mediated by plasmids and transposons. Routine antimicrobial susceptibility testing (disk diffusion or broth microdilution) is recommended to guide therapy and monitor resistance trends. The use of antibiotics for prophylaxis or growth promotion is discouraged to mitigate AMR development.

Supportive Care

Supportive measures include improving ventilation, reducing stocking density, ensuring access to clean water and feed, and removing dead birds promptly. Vitamin and electrolyte supplementation may help support the immune response.

Control

Biosecurity

Strict biosecurity is the cornerstone of fowl cholera prevention. Key measures include:

  • Quarantine: New birds should be isolated for at least 30 days before introduction to the flock.
  • Sanitation: Regular cleaning and disinfection of poultry houses, equipment, and footwear using disinfectants effective against P. multocida (e.g., quaternary ammonium compounds, sodium hypochlorite, phenolics).
  • Rodent and Pest Control: Rodents and wild birds can mechanically transmit the bacterium. Exclusion netting and rodent baiting programs are essential.
  • All-in/All-out Management: Depopulation of the entire facility followed by thorough cleaning and disinfection before restocking reduces the risk of carryover infection.
  • Water Sanitation: Chlorination or acidification of drinking water can reduce bacterial load.

Vaccination

Vaccination is used to reduce the incidence and severity of fowl cholera in endemic areas. Two main types of vaccines are available:

  1. Bacterins (Killed Vaccines): These are inactivated whole-cell preparations administered by intramuscular or subcutaneous injection. They provide protection against homologous serotypes but may not cross-protect against heterologous strains. Bacterins are commonly used in commercial layer and breeder flocks. A booster dose is typically required.

  2. Live Attenuated Vaccines: These are avirulent strains of P. multocida (e.g., serotype 1, strain M-9) administered via drinking water or wing-web stab. They induce a broader immune response, including mucosal immunity, and provide better cross-protection. However, they carry a risk of reversion to virulence and should not be used in flocks with concurrent immunosuppressive diseases.

Autogenous vaccines prepared from the specific P. multocida strain isolated from an outbreak can be used for targeted control in problem flocks.

Eradication

In the event of an outbreak, eradication strategies include quarantine of the affected premises, depopulation of infected and exposed flocks, thorough cleaning and disinfection, and a fallow period of at least 2 to 3 weeks before restocking. Carrier birds should be identified and culled. In some regions, fowl cholera is a notifiable disease, and official veterinary authorities must be informed.

Conclusion

Avian pasteurellosis (fowl cholera) remains a significant threat to poultry health and productivity worldwide. The disease is caused by Pasteurella multocida, a bacterium with a complex capsular and somatic antigenic structure. Effective control relies on a combination of rigorous biosecurity, strategic vaccination, and prudent antimicrobial use. Early and accurate diagnosis, supported by bacteriological culture, molecular typing, and antimicrobial susceptibility testing, is essential for outbreak management. Ongoing surveillance for antimicrobial resistance and the development of improved cross-protective vaccines are critical research priorities for the sustainable control of this disease.

References

  1. Glisson, J. R., Hofacre, C. L., & Christensen, J. P. (2013). Fowl cholera. In D. E. Swayne, J. R. Glisson, L. R. McDougald, L. K. Nolan, D. L. Suarez, & V. Nair (Eds.), Diseases of Poultry (13th ed., pp. 807–823). Wiley-Blackwell.
  2. Christensen, J. P., & Bisgaard, M. (2000). Fowl cholera. Revue Scientifique et Technique (International Office of Epizootics), 19(2), 626–637.
  3. Harper, M., Boyce, J. D., & Adler, B. (2006). Pasteurella multocida pathogenesis: 125 years after Pasteur. FEMS Microbiology Letters, 265(1), 1–10.
  4. Wilkie, I. W., Harper, M., Boyce, J. D., & Adler, B. (2012). Pasteurella multocida: diseases and pathogenesis. Current Topics in Microbiology and Immunology, 361, 1–22.
  5. Townsend, K. M., Boyce, J. D., Chung, J. Y., Frost, A. J., & Adler, B. (2001). Genetic organization of the Pasteurella multocida cap locus and development of a multiplex capsular PCR typing system. Journal of Clinical Microbiology, 39(3), 924–929.
  6. Dabo, S. M., Taylor, J. D., & Confer, A. W. (2007). Pasteurella multocida and bovine respiratory disease. Animal Health Research Reviews, 8(2), 129–150.
  7. Samuel, M. D., Shadduck, D. J., & Goldberg, D. R. (2005). Avian cholera in waterfowl: the role of environmental reservoirs. Journal of Wildlife Diseases, 41(1), 1–12.
  8. Shivaprasad, H. L. (2000). Fowl cholera: a review. Avian Pathology, 29(5), 373–388.
  9. Rhoades, K. R., & Rimler, R. B. (1989). Fowl cholera. In C. Adlam & J. M. Rutter (Eds.), Pasteurella and Pasteurellosis (pp. 95–113). Academic Press.
  10. Blackall, P. J., & Miflin, J. K. (2000). Identification and typing of Pasteurella multocida: a review. Avian Pathology, 29(4), 271–287.
  11. Hunt, M. L., Adler, B., & Townsend, K. M. (2000). The molecular biology of Pasteurella multocida. Veterinary Microbiology, 72(1-2), 3–25.
  12. Boyce, J. D., Harper, M., Wilkie, I. W., & Adler, B. (2010). Pasteurella multocida. In C. L. Gyles, J. F. Prescott, J. G. Songer, & C. O. Thoen (Eds.), Pathogenesis of Bacterial Infections in Animals (4th ed., pp. 325–340). Wiley-Blackwell.
  13. Merck Veterinary Manual. (2020). Fowl Cholera. In Merck Veterinary Manual (11th ed.). Merck & Co., Inc.
  14. World Organisation for Animal Health (WOAH). (2021). Fowl cholera. In Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (12th ed.). WOAH.
  15. Kehrenberg, C., & Schwarz, S. (2001). Occurrence and linkage of genes coding for resistance to sulfonamides, streptomycin, and chloramphenicol in bacteria of the genera Pasteurella and Mannheimia. FEMS Microbiology Letters, 205(2), 283–287.
  16. San Millan, A., Escudero, J. A., Gutierrez, B., Hidalgo, L., Garcia, N., Llagostera, M., Dominguez, L., & Gonzalez-Zorn, B. (2009). Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids. Antimicrobial Agents and Chemotherapy, 53(8), 3399–3404.
  17. Carpenter, T. E., & Hird, D. W. (1986). Time series analysis of fowl cholera outbreaks in California. Preventive Veterinary Medicine, 4(2), 131–142.
  18. Biberstein, E. L. (1990). Pasteurella and Pasteurella-like organisms. In G. R. Carter & J. R. Cole (Eds.), Diagnostic Procedures in Veterinary Bacteriology and Mycology (5th ed., pp. 153–166). Academic Press.
  19. Rimler, R. B., & Rhoades, K. R. (1989). Pasteurella multocida. In C. Adlam & J. M. Rutter (Eds.), Pasteurella and Pasteurellosis (pp. 37–73). Academic Press.
  20. Snipes, K. P., & Carpenter, T. E. (1990). A model for the epidemiology of fowl cholera in turkeys. Avian Diseases, 34(3), 573–581.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.